NCT06208436
Recruiting
Not Applicable
The Survival Outcome of Adjuvant Chemotherapy for Stage I Pancreatic Cancer Stratified by Pathologic Risk Factors
Tianjin Medical University Cancer Institute and Hospital1 site in 1 country250 target enrollmentOctober 7, 2023
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Pancreas Cancer
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Enrollment
- 250
- Locations
- 1
- Primary Endpoint
- Recurrence-free survival
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
This study aimed to evaluate the impact of adjuvant chemotherapy on survival in patients with Stage I pancreatic cancer stratified by pathologic risk factors.
Investigators
Jihui Hao
Professor
Tianjin Medical University Cancer Institute and Hospital
Eligibility Criteria
Inclusion Criteria
- •Patients who underwent surgical resection and were pathologically diagnosed as PDAC between 2010 and
Exclusion Criteria
- •Patients with pN1-N2, patients with pT3-T4, patients with distant metastasis, patients who received neoadjuvant therapy, patients with R1 resection, and patients who died due to perioperative mortality within 30 days.
Outcomes
Primary Outcomes
Recurrence-free survival
Time Frame: January 2010 to February 2023
The period between surgical resection to the date of recurrence.
Secondary Outcomes
- Overall survival(January 2010 to February 2023)
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 3
Immunotherapy Study for Surgically Resected Pancreatic CancerPancreatic CancerNCT01072981NewLink Genetics Corporation722
Recruiting
Phase 3
Adjuvant Chemotherapy in Patients With Clinical Stage III Rectal Cancer Undergoing Neoadjuvant ChemoradiotherapyRectal NeoplasmsNCT03415763LI XIN-XIANG764
Active, not recruiting
Not Applicable
Effect of Adjuvant Chemotherapy Cycles on Patients With Node-negative Gastric Cancer Following Neoadjuvant ChemotherapyLocally Advanced Gastric CancerNCT06277453Fujian Medical University219
Unknown
Phase 3
A Study of Postoperative Adjuvant Chemotherapy for Upper Urinary Urothelial Carcinoma With Lymphovascular InvasionChemotherapy EffectNCT04255771Qinghua Xia,Prof200
Not yet recruiting
Not Applicable
The effect of adjuvant chemotherapy on the prognosis in the patients with familial pancreatic cancer (JON2201-P)Pancreatic cancer treated with postoperative adjuvant chemotherapyJPRN-UMIN000052109Japan Oncology Network in Hepatobiliary and Pancreas (JON-HBP)500